NCT06279390

Brief Summary

Delirium is a severe acute brain dysfunction characterised by sudden confusion, inattention and fluctuating level of consciousness, which mainly affects intubated intensive care patients. It increases the risk of self-extubation, prolongs ICU stay and increases mortality. The incidence of delirium in ICUs varies, with approximately 33.3% of patients affected, and rates of new-onset and pre-existing delirium range from 4% to 89%. Accurate diagnosis is challenging, with 60-80% of patients remaining undiagnosed. Early detection is critical for intervention and improved outcomes. To address these issues, the PREdiction of DELIRium (PRE-DELIRIC) model incorporates 10 risk factors and predicts delirium within 24 hours of ICU admission, allowing risk stratification into low to very high risk categories. It recalibrates predictive values with a sensitivity of 91.3% and specificity of 64.4% using a cut-off score of 27%. However, its integration into delirium management is underexplored. Delirium risk stratification supports efficient resource allocation, cost control, workload reduction and ethical care, while promptly identifying high-risk patients. In this study, Investigators evaluate the integration of the PRE-DELIRIC model into a comprehensive delirium management approach called PRE-DELIRIC-guided SMART/SmART care. SMART care includes improving familiarity, assessing pain and anxiety, reducing equipment discomfort and cognitive stimulation. Patients with PRE-DELIRIC scores \>30% receive SMART care and multidisciplinary involvement, based on the American Delirium Society.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
381

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
Last Updated

February 28, 2024

Status Verified

June 1, 2023

Enrollment Period

5 months

First QC Date

November 12, 2023

Last Update Submit

February 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of delirium

    The incidence of delirium which was assessed by each shift primary ICU nurse by using the ICDSC.

    duration of ICU stay (postoperative 30 days)

Secondary Outcomes (5)

  • duration of ventilator use

    duration of ICU stay( (postoperative 30 days)

  • rate of unplanned self-extubation

    duration of intubation( (postoperative 30 days)

  • day of physical restraint

    duration of ICU stay (postoperative 30 days)

  • level of mobility

    duration of ICU stay (postoperative 30 days)

  • cumulative dose of sedatives

    duration of ICU stay (postoperative 30 days)

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The inclusion criteria encompass patients admitted to a surgical ICU in Taipei, Taiwan, from January 2021 to March 2023.

You may qualify if:

  • \. SICU patients are over 18 years old. 2. received surgery intervention

You may not qualify if:

  • Clinical diagnosis of mental disorders
  • Underwent neurosurgical procedures,
  • Discharged from the ICU within 24 hours of admission
  • Transitioned to active life support withdrawal or "comfort care only" within 24 hours of ICU admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Study Officials

  • Wei Ling Hsiao, Master

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR
  • Man-Ling Wang, Doctor

    National Taiwan University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2023

First Posted

February 28, 2024

Study Start

June 8, 2023

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

February 28, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations